ProfessorThe Second Hospital of Shanxi Medical University, Shanxi, P.R. ChinaTaiyuan, Shanxi, China (People's Republic)
OC 21.5 - An Open-label,Dose-Escalation,Multicenter Phase I Study to Evaluate the Safety,Immunogenicity,and Pharmacokinetics/pharmacodynamics(PK/PD)of Single Dose SS109 in Hemophilia A/B patients with Inhibitor
Sunday, June 23, 202415:45 – 16:00 ICT